Early Postmarket Results with EmboTrap II Stent Retriever for Mechanical Thrombectomy: A Multicenter Experience

References

1. 1.↵
   2. Berkhemer OA,
   3. Fransen PSS,
   4. Beumer D, et al

   . MR CLEAN Investigator. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11–20 doi:10.1056/NEJMoa1411587 pmid:25517348

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Goyal M,
   3. Demchuk AM,
   4. Menon BK, et al

   . ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30 doi:10.1056/NEJMoa1414905 pmid:25671798

   CrossRefPubMed
3. 3.↵
   2. Campbell BCV,
   3. Mitchell PJ,
   4. Kleinig TJ, et al

   . EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015;372:1009–18 doi:10.1056/NEJMoa1414792 pmid:25671797

   CrossRefPubMed
4. 4.↵
   2. Saver JL,
   3. Goyal M,
   4. Bonafe A, et al

   . SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372:2285–95 doi:10.1056/NEJMoa1415061 pmid:25882376

   CrossRefPubMed
5. 5.↵
   2. Jovin TG,
   3. Chamorro A,
   4. Cobo E, et al

   . REVASCAT Trial Investigators; Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372:2296–2306 doi:10.1056/NEJMoa1503780 pmid:25882510

   CrossRefPubMed
6. 6.↵
   2. Albers GW,
   3. Marks MP,
   4. Kemp S, et al

   . DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378:708–78 doi:10.1056/NEJMoa1713973 pmid:9364767

   CrossRefPubMed
7. 7.↵
   2. Nogueira RG,
   3. Jadhav AP,
   4. Haussen DC, et al

   . DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11–21 doi:10.1056/NEJMoa1706442 pmid:29129157

   CrossRefPubMed
8. 8.↵
   2. Zaidat OO,
   3. Bozorgchami H,
   4. Ribó M, et al

   . Primary results of the multicenter ARISE II study (Analysis of Revascularization in Ischemic Stroke with EmboTrap). Stroke 2018;49:1107–15 doi:10.1161/STROKEAHA.117.020125 pmid:29643261

   Abstract/FREE Full Text
9. 9.↵
   2. Valente I,
   3. Nappini S,
   4. Renieri L, et al

   . Initial experience with the novel EmboTrap II clot-retrieving device for the treatment of ischaemic stroke. Interv Neuroradiol 2019;25:271–76 doi:10.1177/1591019918819709 pmid:30714502

   CrossRefPubMed
10. 10.↵
    2. Nogueira RG,
    3. Lutsep HL,
    4. Gupta R, et al

    . TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. The Lancet 2012;380:1231–40 doi:10.1016/S0140-6736(12)61299-9 pmid:22932714

    CrossRefPubMed
11. 11.↵
    2. Chueh J-Y,
    3. Marosfoi MG,
    4. Brooks OW, et al

    . Novel distal emboli protection technology: the EmboTrap. Interv Neurol 2017;6:268–76 doi:10.1159/000480668 pmid:29118805

    CrossRefPubMed
12. 12.↵
    2. Chueh JY,
    3. Puri AS,
    4. Wakhloo AK, et al

    . Risk of distal embolization with stent retriever thrombectomy and ADAPT. J Neurointerv Surg 2016;8:197–202 doi:10.1136/neurintsurg-2014-011491 pmid:25540180

    Abstract/FREE Full Text